Dan Kemp has left Albemarle Street Partners (ASP), less than two years after co-founding the consultancy, to join Morningstar.

Active fund managers must rise to the challenge of a rotation into FTSE 100 stocks after years of outperformance, wealth managers have warned.

Kames' Stephen Snowden has said the bond bears' argument that normalising US and UK monetary policy will be the death knell for fixed income is unfounded.

UBS is formally reducing securities lending on its ETF funds to 50%, following in the footsteps of ETF giant iShares.

Thailand has been gripped by political unrest since last November, with its stock market enduring a tumultuous ride over the last seven months, but which funds have maintained their overweights, and how have they fared?

Hargreaves Lansdown has secured what it says is the cheapest share class in the market for Neil Woodford's new fund, selling the investment star's fund for 60bps.

US pharmaceutical giant Pfizer has abandoned its plans to buy AstraZeneca following an unsuccessful pursuit of its UK rival.

Lloyds Banking Group has announced plans to float a 25% stake in its TSB business next month in a bid to meet European rules on state aid for banks.

Mid-cap stocks have suffered a harsh and indiscriminate sell-off in recent weeks, and managers have pointed to liquidity concerns as a possible trigger for the falls.

Canada Life Investments is going head to head with absolute return giants by launching a new targeted volatility strategic fund, Investment Week can reveal.